BioSpace News Archive

Drug Development

Janssen Touts Positive Data For Tremfya, Stelara

Janssen shared positive updates from ongoing trials on candidate therapies for Crohn’s disease and ulcerative colitis at Digestive Disease Week in San Diego, California.

May 25, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Money on the Move: Biotechs Target Cancers, Dermatology and Strokes

Private investors, governmental institutions and longtime life sciences investors provided funding to develop therapies for cancers, dermatological problems and acute ischemic strokes.

May 25, 2022
·
4 min read
·
Hannah Chudleigh
Pharm Country

FDA Hits Verrica With Third CRL For Lead Drug Candidate VP-102

In the third and most recent FDA letter, Verrica noted that none of the issues were specific to VP-102 and how it is manufactured.

May 25, 2022
·
2 min read
·
Vanessa Doctor, RN
Career Advice

How to Negotiate Stock Options With Your Employer

There are many reasons why you might want to negotiate your stock options. Read on to discover what stock options are and how to negotiate your stock options with your employer.

May 25, 2022
·
5 min read
·
Franklin Carpenter
Policy

Moderna and Pfizer: Lawsuits and Charitable Giving on the Agenda

Monday, Moderna told a Delaware federal court that it was immune from patent-infringement charges over the COVID-19 vaccine because it supplied the vaccine for a U.S. government effort.

May 25, 2022
·
3 min read
·
Mark Terry
Policy

Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid

Concerns are mounting for people that have been given Pfizer’s Paxlovid treatment regimen after contracting COVID-19, only to become positive for the infection once again.

May 25, 2022
·
2 min read
·
Jazmine Colatriano
Business

Samsung to Invest $356 Billion into Chipmaking, Biopharma

Most of Samsung’s investment will be in South Korea, and it expects to create 80,000 new jobs through 2026, or about 16,000 positions annually.

May 25, 2022
·
2 min read
·
Mark Terry
Policy

Lawsuits Galore: J&J, BMS, GSK, Mylan and Others

Johnson & Johnson and Momenta Pharmaceuticals have filed a patent infringement lawsuit over a generic multiple sclerosis drug developed by India-based Natco, Gland Pharma and Mylan.

May 25, 2022
·
2 min read
·
Alex Keown
Chemspace Reopens Kyiv Office to Supply Chemicals to Life Sciences Industry

Three months after the invasion began, Yurii Moroz, the executive director of Kyiv-based Chemspace LLC, has returned to his offices to restart operations.

May 25, 2022
·
2 min read
·
Alex Keown
Drug Development

United Therapeutics Gets FDA Green Light For First Inhaled Hypertension Therapeutic

Tyvaso DPI marks the first approval of a dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

May 25, 2022
·
2 min read
·
Hayley Shasteen